March 23, 2011

Sanofi-aventis Strengthens Commitment to Ophthalmology through Partnership with The Vision Institute

- New Public Private Research Partnership in the Diagnosis, Prevention and Treatment of Ocular Diseases -

 

Sanofi-aventis Strengthens Commitment to Ophthalmology through Partnership with The Vision Institute
- New Public Private Research Partnership in the Diagnosis, Prevention and Treatment of Ocular Diseases -

Paris, France – March 23, 2011 – Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today the official signing of a cooperation agreement between Fovea Pharmaceuticals, its Ophthalmology Division, and the Vision Institute (Institut de la Vision), one of the main eye disease research centers in Europe, for research in the diagnosis, prevention and treatment of ocular diseases.